Biotechnology BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) May 20, 2022
Biotechnology AXSM SHAREHOLDER ALERT: Jakubowitz Law Reminds Axsome Shareholders of a Lead Plaintiff Deadline of July 12, 2022 May 20, 2022
Biotechnology AXSM LAWSUIT ALERT: Levi & Korsinsky Notifies Axsome Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline May 19, 2022
Biotechnology E3 Metals: Unlocking a New Source of Canadian Lithium for a Sustainable Energy Future May 19, 2022
Biotechnology Allogene Therapeutics Announces Oral Presentation of Pre-Clinical Data Highlighting Improved Anti-Tumor Activity of Donor-Derived Allogeneic CAR T Cells at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting May 19, 2022
Biotechnology Amarin Announces Appointment of New Directors and Board Leadership Changes May 19, 2022
Search
investing in biotech
